Literature DB >> 12645722

Mesenteric blood flow response to feeding after systemic-to-pulmonary arterial shunt palliation.

Yiu-fai Cheung1, Marco H K Ho, Vinson Y W Cheng.   

Abstract

BACKGROUND: We hypothesized that the splanchnic circulation protects against diastolic steal through a systemic-to-pulmonary arterial shunt by reducing its resistance. To test the hypothesis we compared the basal and postprandial mesenteric blood flow velocities and vascular resistance in infants after shunt palliation for their underlying cyanotic heart disease with those in nonshunted infants.
METHODS: The basal and postprandial superior mesenteric arterial (SMA) time-average flow velocity (TAMV), end-diastolic flow velocity (EDFV), and relative resistance were assessed in 23 infants with congenital heart disease. The findings in the 9 shunted infants (group I) were compared with those in 14 nonshunted ones (group II).
RESULTS: In group II, TAMV (0.25 +/- 0.07 versus 0.33 +/- 0.09 m/s, p < 0.001) and EDFV (0.08 +/- 0.04 versus 0.11 +/- 0.04 m/s, p = 0.003) increased, while SMA relative resistance decreased (297 +/- 121 versus 198 +/- 73 mm Hg/ms(-1), p < 0.001) postprandially. Similarly, in group I, TAMV (0.35 +/- 0.13 versus 0.48 +/- 0.19 m/s, p = 0.008) increased, while SMA relative resistance decreased (182 +/- 61 versus 116 +/- 38 mm Hg/ms(-1), p = 0.005) after feeding. However, whereas basal and postprandial diastolic flow was antegrade in group II, absent or retrograde diastolic flow was characteristic of group I (preprandial, -0.10 +/- 0.07 m/s; postprandial, -0.13 +/- 0.06 m/s). Furthermore, group I had significantly lower SMA relative resistance both before (p = 0.02) and after (p = 0.006) feeding.
CONCLUSIONS: Profound disturbance of splanchnic perfusion occurs in infants palliated with a systemic-to-pulmonary arterial shunt. Their basal and postprandial SMA diastolic blood flow is either absent or reversed. The lowering of basal and postprandial resistance of the splanchnic circulation probably represents an adaptive mechanism to counteract such diastolic steal.

Entities:  

Mesh:

Year:  2003        PMID: 12645722     DOI: 10.1016/s0003-4975(02)04627-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Comparison of gastrointestinal morbidity after Norwood and hybrid palliation for complex heart defects.

Authors:  Scott L Weiss; Jeffrey G Gossett; Sunjay Kaushal; Deli Wang; Carl L Backer; Eric L Wald
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  Celiac artery flow pattern in infants with single right ventricle following the Norwood procedure with a modified Blalock-Taussig or right ventricle to pulmonary artery shunt.

Authors:  Jason N Johnson; Annette K Ansong; Jennifer S Li; Mingfen Xu; Jessica Gorentz; David A Hehir; Sylvia L del Castillo; Wyman W Lai; Karen Uzark; Sara K Pasquali
Journal:  Pediatr Cardiol       Date:  2011-02-18       Impact factor: 1.655

3.  Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons.

Authors:  Donald McCurnin; Ronald I Clyman
Journal:  Pediatrics       Date:  2008-11-10       Impact factor: 7.124

4.  Development of necrotizing enterocolitis in full-term infants with duct dependent congenital heart disease.

Authors:  Gwang-Jun Choi; Jinyoung Song; Hanna Kim; June Huh; I-Seok Kang; Yun Sil Chang; Se In Sung; Myung Chul Hyun
Journal:  BMC Pediatr       Date:  2022-04-02       Impact factor: 2.125

Review 5.  Necrotizing enterocolitis and congenital heart disease.

Authors:  Hadi Kashif; Eyad Abuelgasim; Nafisa Hussain; Jessica Luyt; Amer Harky
Journal:  Ann Pediatr Cardiol       Date:  2022-03-25

Review 6.  Clinical Characteristics and Potential Pathogenesis of Cardiac Necrotizing Enterocolitis in Neonates with Congenital Heart Disease: A Narrative Review.

Authors:  Kathryn Y Burge; Aarthi Gunasekaran; Marjorie M Makoni; Arshid M Mir; Harold M Burkhart; Hala Chaaban
Journal:  J Clin Med       Date:  2022-07-09       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.